Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Enterprise Value (2020 - 2023)

Cullinan Therapeutics (CGEM) has 4 years of Enterprise Value data on record, last reported at -$466.4 million in Q3 2023.

  • For Q3 2023, Enterprise Value rose 48.7% year-over-year to -$466.4 million; the TTM value through Sep 2023 reached -$466.4 million, up 48.7%, while the annual FY2022 figure was -$467.3 million, 61.1% down from the prior year.
  • Enterprise Value reached -$466.4 million in Q3 2023 per CGEM's latest filing, up from -$841.8 million in the prior quarter.
  • Across five years, Enterprise Value topped out at $1.9 million in Q3 2020 and bottomed at -$909.3 million in Q3 2022.
  • Average Enterprise Value over 4 years is -$479.2 million, with a median of -$466.9 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: crashed 36399.03% in 2021, then soared 48.7% in 2023.
  • A 4-year view of Enterprise Value shows it stood at -$208.9 million in 2020, then plummeted by 38.85% to -$290.1 million in 2021, then crashed by 61.1% to -$467.3 million in 2022, then increased by 0.18% to -$466.4 million in 2023.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$466.4 million in Q3 2023, -$841.8 million in Q2 2023, and -$659.3 million in Q1 2023.